Diane E. Wilfong - 06 Feb 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
SVP, Controller & CAO
Signature
/s/ Edward S. Son by Power of Attorney for Diane E. Wilfong
Issuer symbol
GILD
Transactions as of
06 Feb 2023
Net transactions value
-$48,793
Form type
4
Filing time
07 Feb 2023, 16:47:01 UTC
Previous filing
26 Jan 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +1,864 +6.1% 32,575 06 Feb 2023 Direct F1
transaction GILD Common Stock Tax liability $48,793 -565 -1.7% $86.36 32,010 06 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -1,864 -14% 11,060 06 Feb 2023 Common Stock 1,864 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the yearly anniversary of the date of grant until fully vested.